“…Two weeks after recovering from surgery, the OVX rats were randomly divided into six groups: OVX/Mock, OVX/1X kefir (164 mg/kg BW/day), OVX/2X kefir (328 mg/kg BW/day), OVX/4X kefir (656 mg/kg BW/day), OVX/ALN (2.5 mg/kg BW/day), and OVX/REBONE (800 mg/kg BW/day). The daily doses of kefir and ALN were based on the doses of the references [12,21], and REBONE was based on prescription drug information. An aminobisphosphonate (ALN) employed as an antiresorptive agent in the treatment of osteoporosis was used as a positive therapy control.…”